60 Degrees Pharmaceuticals (SXTP) EPS (Basic) Growth (1y) (2023 - 2026)
60 Degrees Pharmaceuticals (SXTP) EPS (Basic) Growth (1y) (2023 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Basic) Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 140.52 Bn | 132.67 Bn | 2.84 Bn | 7.74% |
| 2 | Regeneron Pharmaceuticals | 86.54 Bn | 78.55 Bn | 3.93 Bn | -4.72% |
| 3 | Argenx Se | 65.31 Bn | 60.13 Bn | 1.37 Bn | 88.81% |
| 4 | Moderna | 61.77 Bn | 56.64 Bn | 52.00 Mn | 7.59% |
| 5 | BeOne Medicines | 42.26 Bn | 37.16 Bn | 1.53 Bn | 143.95% |
| 6 | Alnylam Pharmaceuticals | 31.19 Bn | 27.88 Bn | 992.69 Mn | 322.67% |
| 7 | BioNTech SE | 28.71 Bn | 10.31 Bn | 668.28 Mn | -147.33% |
| 8 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn | 96.41% |
| 9 | Royalty Pharma | 27.35 Bn | 26.52 Bn | - | -16.29% |
| 10 | 60 Degrees Pharmaceuticals | 2.97 Mn | 1.95 Mn | 56,798.00 | 81.90% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 80.61% |
| Dec 31, 2025 | 92.38% |
| Sep 30, 2025 | 86.44% |
| Jun 30, 2025 | 94.42% |
| Mar 31, 2025 | -185.37% |
| Dec 31, 2024 | 84.76% |
| Sep 30, 2024 | -110.08% |
| Jun 30, 2024 | 74.91% |
| Mar 31, 2024 | 102.70% |
| Dec 31, 2023 | 25.05% |
| Sep 30, 2023 | 226.26% |
| Jun 30, 2023 | -53.34% |